Results 211 to 220 of about 151,006 (313)
Writer-Speaker? Narrative and Cultural Intervention In Mario Vargas Llosa\u27s \u3cem\u3eEl hablador\u3c/em\u3e [PDF]
Cruz, Maria Isabel Acosta
core +1 more source
Abstract Online technologies are required for accessing essential services, such as healthcare, transportation, and education. Challenges to online technology access can prevent resource‐constrained communities from connecting to these services. Human intermediaries who act in the middle space between technology and the person using the technology may ...
Marcy G. Antonio +4 more
wiley +1 more source
The effects of health fatalism and cyberchondria on parents' childhood vaccine hesitancy. [PDF]
Sarpdaği Y +6 more
europepmc +1 more source
Autism Spectrum Disorder Among Gender‐Diverse Children and Adolescents: A National Cohort Study
ABSTRACT Autism spectrum disorder (ASD) is more prevalent in transgender and gender‐diverse (TGD) individuals than in the general population, yet the specific developmental pathways within and clinical outcomes of this intersection are insufficiently understood.
Erez Topaz +7 more
wiley +1 more source
Behavioural and Social Drivers (BeSD) of COVID-19 vaccination for children: A cross-sectional study of parental vaccine confidence and intent in Mysore, India. [PDF]
Muralidhar K +11 more
europepmc +1 more source
Abstract Aims In the context of pharmacology and toxicology education, there is a growing shift toward programmatic assessment models that prioritize longitudinal learning, reflection and development of higher‐order cognitive skills. As part of this transition, we are exploring alternative and more meaningful forms of assessment. This qualitative study
Narin Akrawi +2 more
wiley +1 more source
Lessons Learnt From COVID-19 Vaccine Hesitancy: The Role of Culturally Concordant Providers. [PDF]
Padala KP, McGeeBlanks I, Padala PR.
europepmc +1 more source
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden +3 more
wiley +1 more source

